Suppr超能文献

皮肤黑色素瘤患者的种族差异。

Ethnic differences among patients with cutaneous melanoma.

作者信息

Cormier Janice N, Xing Yan, Ding Meichun, Lee Jeffrey E, Mansfield Paul F, Gershenwald Jeffrey E, Ross Merrick I, Du Xianglin L

机构信息

The University of Texas M. D. Anderson Cancer Center, Houston, USA.

出版信息

Arch Intern Med. 2006 Sep 25;166(17):1907-14. doi: 10.1001/archinte.166.17.1907.

Abstract

BACKGROUND

Melanoma incidence continues to increase in whites, but little is known about melanoma in minority populations. Surveillance, Epidemiology, and End Results (SEER) data were used to examine the incidence, manifestations, and survival in patients with melanoma with respect to race/ethnicity.

METHODS

A SEER search (1992-2002) for primary invasive cutaneous melanoma cases identified 48 143 whites, 932 Hispanics, 394 Asian/Pacific islanders, 251 African Americans, and 52 American Indians. Multivariate analyses were performed to evaluate the relationship between race/ethnicity and clinicopathologic factors; associations between race/ethnicity and survival were examined using the Cox proportional hazards model.

RESULTS

Based on our cohort of patients, the average annual age-adjusted melanoma incidence per 100 000 persons was 18.4 for whites compared with 2.3, 0.8, 1.6, and 1.0 for Hispanics, African Americans, American Indians, and Asians, respectively. Lower extremity and acral lentiginous melanomas were more common among minorities. Overall 5-year survival was 72.2% to 81.1% for minorities compared with 89.6% for whites. A 1.96- to 3.01-fold greater risk of disease-specific mortality persisted in minorities compared with whites after adjusting for age, sex, and region. In addition, Hispanics (odds ratio [OR], 3.6), African Americans (OR, 4.2), American Indians (OR, 3.4), and Asians (OR, 2.4) were more likely to present with stage IV melanoma than were whites. African Americans had a 1.48-fold higher rate of risk-adjusted, stage-specific mortality compared with whites.

CONCLUSIONS

Melanoma is a public health concern for all ethnic populations. Differences in disease stage at presentation contributes to disparities in survival. Understanding melanoma in minority populations may lead to early detection and ultimately save lives.

摘要

背景

白人中黑色素瘤的发病率持续上升,但对于少数族裔人群中的黑色素瘤了解甚少。利用监测、流行病学和最终结果(SEER)数据来研究黑色素瘤患者在种族/民族方面的发病率、表现及生存率。

方法

通过SEER数据库检索(1992 - 2002年)原发性侵袭性皮肤黑色素瘤病例,共识别出48143名白人、932名西班牙裔、394名亚裔/太平洋岛民、251名非裔美国人以及52名美洲印第安人。进行多变量分析以评估种族/民族与临床病理因素之间的关系;使用Cox比例风险模型检验种族/民族与生存率之间的关联。

结果

基于我们的患者队列,每10万人中经年龄调整后的黑色素瘤年平均发病率,白人是18.4,而西班牙裔、非裔美国人、美洲印第安人和亚裔分别为2.3、0.8、1.6和1.0。下肢和肢端雀斑样痣黑色素瘤在少数族裔中更为常见。少数族裔的总体5年生存率为72.2%至81.1%,而白人为89.6%。在调整年龄、性别和地区后,少数族裔与白人相比,疾病特异性死亡风险仍高出1.96至3.01倍。此外,西班牙裔(优势比[OR],3.6)、非裔美国人(OR,4.2)、美洲印第安人(OR,3.4)和亚裔(OR,2.4)比白人更有可能出现IV期黑色素瘤。非裔美国人与白人相比,风险调整后的特定阶段死亡率高出1.48倍。

结论

黑色素瘤是所有族裔人群的公共卫生问题。就诊时疾病分期的差异导致了生存率的差异。了解少数族裔人群中的黑色素瘤可能有助于早期发现并最终挽救生命。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验